Opendata, web and dolomites

GutILC3

Cell-cell interactions critical to ILC3 function in the human gut

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GutILC3 project word cloud

Explore the words cloud of the GutILC3 project. It provides you a very rough idea of what is the project "GutILC3" about.

mononuclear    hosting    building    me    mouse    intestinal    techniques    critical    provides    monitoring    immune    players    excellent    22    ilc3    extensive    cd4    papers    maintaining    cells    human    etiology    unknown    possibilities    insights    phagocytes    cellular    interacting    microbes    intestine    genetically    record    society    disease    producing    discovered    interaction    track    infrastructure    ultimate    dramatically    unravel    conferring    materials    skill    risk    ilcs    inappropriate    therapy    translational    lymphoid    inflammatory    crc    bowel    reporting    host    utilizes    therapies    seem    gamma    career    il    group    purpose    interestingly    manner    ibd    colorectal    direct    cancer    feasibility    model    interactions    suitable    mucosal    training    colitis    exact    ifn    degree    optimal    innate    molecules    patient    prospects    17    crosstalk    truly    ensures    inflammation    progression    modulating    susceptible    homeostasis    pinpoint   

Project "GutILC3" data sheet

The following table provides information about the project.

Coordinator
KAROLINSKA INSTITUTET 

Organization address
address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177
website: www.ki.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 173˙857 €
 EC max contribution 173˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-04-01   to  2017-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET SE (STOCKHOLM) coordinator 173˙857.00

Map

 Project objective

Inflammatory bowel disease (IBD), conferring a dramatically increased risk for development of colorectal cancer (CRC), results from an inappropriate inflammatory response to intestinal microbes in a genetically susceptible host. However, the exact etiology of IBD is unknown. Building up on high impact papers from the host group reporting on the recently discovered innate lymphoid cells (ILCs) as key players in mucosal inflammation, I now aim to unravel the role for ILCs in IBD and CRC. Interestingly, while the IL-22 producing ILC3 seem to be crucial in maintaining intestinal homeostasis, the IL-17 and IFN-gamma-producing ILCs can cause inflammation in a mouse model of colitis and are present in human IBD. Furthermore, ILCs were recently described to be involved in modulating immune responses, by interacting with CD4 T cells and mononuclear phagocytes in the mouse intestine. I aim to identify critical pathways in the crosstalk of ILC3 with other immune cells in the human intestine. The ultimate purpose is to assess how these interactions affect immune homeostasis and disease progression in IBD and CRC. We will pinpoint crucial interaction molecules and cellular processes that can be used for monitoring current therapies as well as finding new therapy targets for IBD and CRC. This truly translational proposal utilizes, in an optimal manner, unique state-of-the-art techniques and patient materials to provide novel insights into the etiology of IBD and CRC. The excellent track record of the hosting group, the highly suitable infrastructure provided by the host institution and my own extensive research experience ensures a high degree of feasibility. Furthermore, this project provides excellent training opportunities, skill advancement possibilities and career prospects for me and its results are expected to have a direct impact on the European society.

 Publications

year authors and title journal last update
List of publications.
2015 V. Konya, J. Mjösberg
Innate Lymphoid Cells in Graft-Versus-Host Disease
published pages: 2795-2801, ISSN: 1600-6135, DOI: 10.1111/ajt.13394
American Journal of Transplantation 15/11 2019-07-23
2016 Åsa K Björklund, Marianne Forkel, Simone Picelli, Viktoria Konya, Jakob Theorell, Danielle Friberg, Rickard Sandberg, Jenny Mjösberg
The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing
published pages: 451-460, ISSN: 1529-2908, DOI: 10.1038/ni.3368
Nature Immunology 17/4 2019-07-23
2016 Viktoria Konya, Jenny Mjösberg
Lipid mediators as regulators of human ILC2 function in allergic diseases
published pages: 36-42, ISSN: 0165-2478, DOI: 10.1016/j.imlet.2016.07.006
Immunology Letters 179 2019-07-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GUTILC3" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GUTILC3" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

DEMOS (2019)

Disfluencies and Eye MOvements during Speech: what can they reveal about language production?

Read More  

MIGPSC (2018)

Shaping the European Migration Policy: the role of the security industry

Read More  

EPIC (2019)

Evolution of Planktonic Gastropod Calcification

Read More